Background {#Sec1}
==========

Retroperitoneal tumors often present diagnostic and therapeutic challenges. Although computed tomography (CT) and magnetic resonance imaging (MRI) may be useful for diagnosis and understanding the extent of disease, a definitive diagnosis can be established only by histopathologic analysis after surgery. Knowledge of the tumor characteristics may help to narrow down the differential diagnosis. Here, we report a case of a giant multilocular prostatic cystadenoma, an extremely rare benign neoplasm that originates in the prostate glands. Fewer than 30 cases have been reported thus far \[[@CR1]--[@CR21]\]. Our case was one of the largest reported to date, as it measured 33 cm in length and occupied the whole pelvis up to the level of the navel.

Case presentation {#Sec2}
=================

A 50-year-old man presented with a 2-year history of abdominal distension. He also had lower urinary symptoms such as the sensation of incomplete voiding and increased frequency. He had no symptoms of bowel obstruction. Physical examination revealed a palpable mass occupying the lower abdomen up to the level of the navel, but there was no tenderness. Digital rectal examination revealed an elastic hard mass on the anterior side of the rectum without palpable intraluminal mass. Total colonoscopy showed no masses or stenosis in the rectum. We evaluated the urinary symptoms were due to the compression of the bladder by the tumor.

The results of laboratory tests were normal. Serum prostate-specific antigen (PSA) was not available preoperatively. Urinalysis was normal, with no evidence of hematuria. Enhanced CT showed a large retroperitoneal mass measuring 30 cm in size with multiple septations surrounding the rectum and displacing the bladder, prostate, and seminal vesicle to the right anterior side (Fig. [1](#Fig1){ref-type="fig"}). MRI showed a mass composed of cysts of various sizes ranging from smaller than 1 up to 6 cm and solid components. Whereas most cysts had simple fluid appearance (very high intensity on T2-weighted images), some showed the presence of layering which suggests the likelihood of either fat or blood in content (Fig. [2](#Fig2){ref-type="fig"}a, b). Several solid components which showed isointensity on T2-weighted images were enhanced on gadolinium-enhanced fat-saturated T1-weighted images (Fig. [2](#Fig2){ref-type="fig"}c--f). From these radiological findings, preoperative diagnosis was leiomyoma with cystic degeneration or perivascular epithelioid cell tumor (Fig. [2](#Fig2){ref-type="fig"}). Biopsy of the mass was performed under CT guidance, and histology showed a spindle cell tumor. Immunohistochemically, preoperative biopsy of the tumor showed positive staining for SMA, desmin, and caldesmon while negative for S-100, HMB-45, and MDM2, indicating smooth muscle differentiation. Differential diagnosis of leiomyoma, low-grade leiomyosarcoma, and perivascular epithelioid cell tumor was made. We suspected the tumor originated from the smooth muscle of the bladder or deep soft tissue in the retroperitoneal space.Fig. 1Enhanced abdominal CT. **a**, **b**, **c** A large multilocular mass with soft tissue component displacing the bladder (\*) and rectum anterolaterally. **d** The arrow shows the prostateFig. 2**a**, **b** T2-weighted MRI. Most cysts showed high intensity suggesting simple fluid, and some showed the presence of layering which suggests the likelihood of either fat or blood in content. The arrowheads show the presence of layering within the cystic areas. **c**, **d** Non-enhanced fat-saturated T1-weighted MRI and **e**, **f** gadolinium-enhanced fat-saturated T1-weighted MRI. Several solid components were enhanced

As the biopsy findings did not reveal obvious evidence of malignancy and because the outer wall of the tumor was relatively smooth, we chose to forego total pelvic exenteration and instead attempt complete macroscopic resection of the tumor with minimal combined resection of adjacent organs.

Laparotomy was performed through a midline incision, which revealed a huge mass from the pelvic floor up to the level of the navel (Fig. [3](#Fig3){ref-type="fig"}). During exploration, the bilateral ureter was preserved but the vas deferens was resected. Because the plane of the interface between the bladder and tumor was unrecognizable, we injected air into the bladder and identified the border of the mass. We dissected the tumor, preserving the bladder and prostate with partial resection of the prostate. The tumor was not attached to the sacrum or levator ani and was mobilized from the pelvic floor. Because the tumor extended into the left pelvic sidewall and surrounded the rectum, we sacrificed the rectum as well as the left hypogastric nerve and left pelvic plexus. Finally, we performed a complete resection of the tumor with low anterior resection. Intraoperatively, the border between the tumor and normal prostate was not so clear.Fig. 3Intraoperative view. Large mass with a smooth surface in the lower abdomen and pelvis

The gross pathologic specimen was a 33 × 23 × 10 cm solid mass containing multilocular cavities. Sectioning revealed a multicystic cut surface (Fig. [4](#Fig4){ref-type="fig"}), and blackish-brown intratumoral fluid was drained from the tumor. Histologically, the tumor was composed of variously sized dilated glandular structures lined by prostatic epithelia surrounded by fibromuscular stroma (Fig. [5](#Fig5){ref-type="fig"}a). Lesions of the well-developed, dilated prostate glands resembling prostatic hyperplasia were also evident (Fig. [5](#Fig5){ref-type="fig"}b). The cysts were lined by cuboidal to columnar secretory cells and basally located nuclei (Fig. [5](#Fig5){ref-type="fig"}c). Cytologically, we observed no atypical features or mitosis. Epithelial cells of the cysts and stromal glands were positive for PSA on immunohistochemical staining (Fig. [5](#Fig5){ref-type="fig"}d). The epithelium cells of the tumor were also positive for AR and NKX3.1 staining, indicating that the tumor originated from the prostate. The spindle cells seen on preoperative biopsy were thought to be stromal components of the tumor.Fig. 4Gross photograph. Sectioning revealed a multicystic cut surfaceFig. 5Pathological examination of the resected specimen. **a** Low-power magnification of cystadenoma of the prostate with dense fibromuscular stroma (H&E, original magnification × 20). **b** Cystic dilated glandular structures surrounded by a fibrous stroma resembling prostatic hyperplasia (H&E, original magnification × 20). **c** Glands and cysts are lined by cuboidal to low columnar epithelial cells with basally located nuclei (H&E, original magnification × 40). **d** The epithelium of the cysts stained positively with prostate-specific antigen stain (× 20)

Final histology indicated a giant multilocular prostatic cystadenoma.

Postoperatively, whereas the patient developed a pelvic abscess due to urine leakage from the prostatic urethra, he recovered conservatively and was discharged on postoperative day 37. Since there is no positive evidence of adjuvant therapy of this prostatic cystadenoma, the patient is now under follow-up by blood tests and CT scan every 3--6 months.

At 2 months after surgery, the patient had a PSA of 0.365 ng/ml, which was within the normal ranges. Since then, we have observed no signs of tumor recurrence. The patient was completely asymptomatic at the 6-month follow-up visit and made a full recovery, with no complaints of any urinary disorders or sexual dysfunction.

Discussion and conclusions {#Sec3}
==========================

A giant multilocular prostatic cystadenoma is an extremely rare benign neoplasm that originates in the prostate glands. In 1991, Maluf et al. became the first to describe and designate this rare entity \[[@CR2]\]; since then, fewer than 30 cases have been reported (Table [1](#Tab1){ref-type="table"}) \[[@CR1]--[@CR21]\]. This type of tumor is typically located along the midline between the bladder and rectum and identified as a large retroperitoneal mass. A definitive diagnosis before histological examination of a surgical biopsy is very difficult, but preoperative assessment is important for surgical treatment planning. Previous reports of giant multilocular prostatic cystadenomas indicate that surgical treatment varies from tumor debulking to total pelvic exenteration. The decision concerning surgical margin is influenced by whether or not the mass is malignant in nature and whether it has invaded adjacent organs. Information on the origin of the mass is also necessary in order to preserve adjacent organs.Table 1Cases of giant multilocular prostatic cystadenomaReferenceYearNo. of casesAge (years)Clinical symptomsPSA (ng/ml)BiopsyRadiologic findingsSize (cm)Volume (g)ContentsTreatmentFolllow-upOutcomeWatanabe et al.1990180urinary retention8.2connective tissuelarge tumor in the pelvic cavity11 × 8 × 7660cloudy fluid similar to semenanterior pelvic exenteration2 yearsno recurrenceMaluf et al.1991228Urinary retentionNAFragments of prostatic tissueNA19 × 16 × 7600Brown fluid and others with gray colorSurgical excision4 monthsNo recurrence38Increasing abdominal girth, difficulty in micturitionNANANA45 × 35 × 136500Serous, serosanguinous, or mucinous fluidResection → exenteration and pelvic irradiation2 yearsNo recurrenceLim et al.1993164Lower abdominal pain, obstructive voiding symptomsNANAFluid-filled mass17 × 13 × 7NANAEn bloc excisionNANALevy et al.1993156Decreased force of urinary stream, hesitancy and frequency of urinationNANegative for malignant cells (cytology)Multi-septated pelvic mass with thickened irregular walls13 × 10 × 7NAYellowish-brown fluidComplete surgical excision8 yearsNo recurrenceMorimoto et al.1994145Urinary retention6Benign prostatic tissueA mass with multilocular structure at the position of the prostate5.5 × 5 × 5210Yellow fluidSurgical resection9 monthsNo recurrenceKirsch et al.1996165Hemorrhoidal pain, obstructive voiding symptoms, gross hematuria30.2No evidence of malignancy (cystic component)Heterogeneous mass arising from the prostate and extending to the level of the sacral promontory15 × 12.5 × 3130Straw-colored fluidFull enucleation1 yearNo recurrenceChoi et al.2000157Lower abdominal mass and dysuriaNANALarge multiseptated pelvic mass with thickened irregular walls15 × 10 × 8300Brown, rusty appearing fluid, transparent serous fluidSurgical resectionNANASeong et al.2002148Gross hematuria and frequency68.2Chronic inflammatory lesionOval, low-attenuated mass between the bladder and rectum, containing cystic and solid portions8 × 7.5 × 6180Reddish-brown serous fluidExcision with bilateral seminal vesicles and vas deferensNANo recurrenceMatsumoto et al.2002135Gross hematuria14.4NA (abandoned)Multilocular mass replacing the prostatic gland9 × 8 × 6860Reddish-brown serous fluidRadical cystoprostatectomy24 monthsNo recurrenceRusch et al.2002230Urinary retention, lower urinary tract symptomsNABenign prostatic tissue with cystic dilatation of glands and no evidence of malignancyMultiple septations with some soft-tissue components15NAHemorrhagic fluidSurgical resection18 monthsNo recurrence41Urinary retention (recurrence)NANAMultiseptated cystic mass15NANASurgical excisionNANADatta et al.2003171Urinary retentionNANACystic pelvic mass12 × 7 × 4.5NANACystoprostatectomy and removal of a portion of the rectum, GnRH antagonist11 yearsRecurrence and hormonal therapyAllen et al.2003152Lower urinary tract symptoms, gross hematuria3NAMultiloculated cystic pelvic mass14 × 10 × 1NANACompletely removed piecemeal with the largest tissue fragmentNANAGanesan et al.2006128Reduced force of the urinary stream and hesitancy and frequency of urination1.6Cystic lesion lined by columnar epithelium with cystic dilatation of prostatic aciniCystic mass with multiple thin, echogenic internal septations (transabdominal ultrasound)9.9 × 8.5 × 7.3NAStraw-colored fluidDebulkingNANATuziak et al.2007242Obstructive urinary symptoms, urinary retention0.04Fibrous tissue interspersed with prostatic glands having no atypical featuresMulticystic pelvic mass15NANAOpen prostatectomy without seminal vesicle removal2 yearsNo recurrencePark et al.2007161Abdominal distension, urinary retention, aspermia38.2NAMass located between the rectum and bladder9 × 7NANAMass excision1 yearNo recurrenceChowdhury et al.2009135Left loin pain, hematuria, micturitionNANAComplex septated cystic/soft tissue mass20 × 11 × 15NANADebulkingNANALee et al.2010171Urinary tract obstructionNANAMultilocular heterogenous cystic pelvic mass posterior to the bladder and anterior to the rectum10 × 6.5 × 5.5NADark brown hemorrhagic fluidRadical cystoprostatectomy1 yearNo recurrenceOlgun et al.2012123Obstructive voiding symptom, difficulty in defecation20.2Only red blood cells and histiocytes with groups of benign epithelial cellsMultiseptated, huge cystic lesion that filled the pelvis completely7 × 5 × 2.5 solid mass, 9 × 9 × 0.2 cystic componentNASerous and mucinous fluidsDebulking of the mass18 monthsNo recurrenceBaad et al.2015155Acute urinary retention, gross hematuria, lower abdominal pain9.8Benign prostatic tissueMutilocular, retrovesicular midline mass with multiple thin septations11 × 9 × 7NAStraw-colored fluidPartial prostatectomy with enucleation of the massNANARahman et al.2016174Hypogastric pain, constipation, obstructive voiding symptom20.5Benign prostatic tissueMultiloculated cystic pelvic mass, peripheral contrast enhancement11.6 × 9 × 8NADense brown liquidLaparoscopic48 monthsNo recurrenceOur case2018150Abdominal distension, lower urinary symptomNASpindle cell tumor with focal smooth muscle differentiationMultiloculated cystic mass32 × 23 × 103000Blackish-brown fluidSurgical resection6 monthsNo recurrence*NA* not available

Clinical presentation and radiographic features are helpful for preoperative diagnosis. As shown in Table [1](#Tab1){ref-type="table"}, giant multilocular prostatic cystadenoma may occur at any age, with reported patient ages ranging from 23 to 80 years at diagnosis. Presenting symptoms are similar to those of benign prostatic hyperplasia and include incomplete voiding and urinary retention. Almost all cases in the literature noted lower urinary symptoms. Enlargement of the mass also causes abdominal distension and gastrointestinal symptoms. Our case initially presented with complaints of abdominal distension, but a detailed interview revealed these to be lower urinary symptoms. Urinalysis often reveals hematuria and elevated serum PSA levels.

Imaging findings of retroperitoneal tumors are often overlapping, and the first step to understanding the tumors is to divide them into solid or cystic tumors. In addition, their content, precise localization, extent of local invasion, and vascularity may help to define a specific differential diagnosis \[[@CR22]\]. CT and MRI scans of the present giant multilocular prostatic cystadenoma revealed a large retroperitoneal solid mass with multilocular cavities that were compressing adjacent organs, especially the bladder and rectum. As it was located between the bladder and rectum, it was presumed to have arisen from the prostate gland. The mass comprised cysts of various sizes and soft tissue components. MRI may provide additional information, and T2-weighted imaging of the cysts can be suggestive of either fat or blood in the content. MRI may also show attachment to the prostate.

Differential diagnoses of a multicystic retroperitoneal tumor can include liposarcoma, leiomyoma with cystic degeneration, lymphangioma, multilocular peritoneal inclusion cyst, phyllodes variant of atypical prostatic hyperplasia, prostatic abscess, and teratoma. Cysts of the lower male genitourinary tract are uncommon. There are also differential diagnoses for cystic lesions in the pelvis, including Müllerian cysts, utricle cysts, and seminal vesicle cysts. However, these are typically smaller than the giant multilocular prostatic cystadenoma and not "multilocular" \[[@CR23]\].

Although imaging studies may provide useful information about the extent of the lesion and invasion to adjacent organs, a clear and definitive diagnosis is possible only through histological means. Histologically, a giant multilocular prostatic cystadenoma is composed of multiple cysts in hypocellular fibrous stromal tissue and dense fibrous stroma that corresponds to a focal solid area. It is characterized by cuboidal cells lining the prostate glands and cyst, with positive immunohistochemical staining for PSA in epithelial cells \[[@CR2]\]. No previous studies have reported a diagnosis of giant multilocular prostatic cystadenoma preoperatively by biopsy, and biopsy showed benign prostatic glands and stroma in some reports. The biopsy sample of the tumor in our case showed a spindle cell tumor with focal smooth muscle differentiation \[[@CR2], [@CR24]\]. If we could diagnose multilocular prostatic cystadenoma before surgery, that is, if we could suspect that the tumor originated from prostate, we might be able to preserve a normal prostate without prostatic urethra injury.

Treatment for giant multilocular prostatic cystadenoma is complete surgical excision. However, adherence to surrounding structures often makes complete resection difficult, and clinical suspicion of malignancy may lead to unnecessarily aggressive surgery and no preservation of urogenital or digestive organs. Despite its benign nature, incomplete resection can result in recurrence \[[@CR2], [@CR12]\]. To achieve complete resection, we sacrificed the rectum as well as the left hypogastric nerve and left pelvic plexus, but were able to preserve adjacent organs including the prostate, which resulted in no urinary disorders or sexual dysfunction. Complete resection of giant multilocular prostatic cystadenoma should be considered in light of the surgical trauma involved.

One recent report found that a gonadotropin-releasing hormone antagonist is effective for recurrent giant multilocular prostatic cystadenoma \[[@CR12]\], and this may represent a new treatment option for patients with more aggressive or recurrent giant multilocular prostatic cystadenoma.

In conclusion, when a retroperitoneal huge lesion with locular cavities fills the pelvis in men, giant multilocular prostatic cystadenoma should be considered as a differential diagnosis.
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